Accueil   Diary - News   All news ERYTECH announces management change

ERYTECH announces management change

ERYTECH, the French biopharmaceutical company that develops innovative ‘tumor starvation’ treatments for acute leukemia and other oncology indications with unmet medical needs, today announced that Pierre-Olivier Goineau will be leaving the company to pursue other interests. Pierre-Olivier Goineau was one of the co-founders of the company and has been instrumental in advancing the business both in terms of its operational and financial performance as co-founder and CEO and since 2013 as COO.


The search for a replacement has been initiated. During the transition phase, Pierre-Olivier will continue to support the company on a consulting basis, notably in the continuation of the building of US operations. 


“In name of the Board and the entire company we wish to thank Pierre-Olivier for his valuable contributions to the
company and wish him the best of success in his future endeavors” comments Gil Beyen, Chairman & CEO of the


Read the press release